Shareholder Rights Law Firm Gilman Law LLP has commenced a breach of fiduciary duty investigation on behalf of current shareholders of IntegraMed America, Inc. (Nasdaq: INMD) (“IntegraMed”) and other violations of state law by the board of directors of IntegraMed relating to the proposed buyout of the company by affiliates of the investment firm Sagard Capital Partners, L.P. (“Sagard Capital”). Gilman Law LLP’s investigation focuses on determining whether the board breached its fiduciary duties by failing to maximize shareholder value in the proposed InregraMed Acquisition. Join the IntegraMed American Acquisition Lawsuit
- Contact: Kenneth Gilman, Esq.
- Toll Free: (888) 252-0048
- E-mail: firstname.lastname@example.org
- Website: IntegraMed American Lawsuit Claim Form